Fosifidancitinib

CAS No. 1237168-58-9

Fosifidancitinib( —— )

Catalog No. M28194 CAS No. 1237168-58-9

Fosifidancitinib is a potent inhibitor of JAK 1 and JAK 3.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 120 In Stock
5MG 187 In Stock
10MG 283 In Stock
25MG 452 In Stock
50MG 631 In Stock
100MG 848 In Stock
200MG 1135 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fosifidancitinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Fosifidancitinib is a potent inhibitor of JAK 1 and JAK 3.
  • Description
    Fosifidancitinib is a potent inhibitor of JAK 1 and JAK 3.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    JAK
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1237168-58-9
  • Formula Weight
    505.39
  • Molecular Formula
    C21H21FN5O7P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1cc(Nc2ncc(C)c(Nc(cc3)cc(N4COP(O)(O)=O)c3OC4=O)n2)cc(OC)c1F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kungl AJ, et al. Molecular dynamics simulation of the rare amino acid LL-dityrosine and a dityrosine-containing peptide: comparison with time-resolved fluorescence. Biochim Biophys Acta. 1994 Dec 15;1201(3):345-52.
molnova catalog
related products
  • PF-06700841 (P-Tosyl...

    PF-06700841 P-Tosylate is a potent dual inhibitor of Janus kinase 1 (JAK1) and TYK2 (IC50s of 17 nM and 23 nM, respectively).

  • BMS-986165

    BMS-986165 is differentiated from previous JAK inhibitors due its unique ability to selectively bind to the pseudokinase (JH2) domain of TYK2 and inhibit its function through an allosteric mechanism.

  • Tyk2-IN-30

    TYK2-IN-30 is a potent, selective and orally active Tyk2 inhibitor with Ki of 0.7 nM.